BACE1 Gene: Beta-Secretase 1 - Function, Disease Associations, and Expression

Comprehensive resource on the BACE1 gene, including genomic information, protein function, expression patterns, mutations, and related diseases.

Gene Information Card

Symbol BACE1
Full Name beta-secretase 1
Gene Type gene with protein product
Chromosomal Location 11q23.3
NCBI Gene ID 23621 ncbi.nlm.nih.gov/gene/23621
Ensembl ID ENSG00000186318
UniProt ID P56817
OMIM ID 604252
HGNC ID HGNC:933
Aliases Asp2, BACE

Description

The BACE1 gene encodes beta-secretase 1, a transmembrane aspartic protease that cleaves the amyloid precursor protein (APP) to generate amyloid-beta peptides, which are the major component of amyloid plaques in Alzheimer's disease. BACE1 is a key therapeutic target for Alzheimer's disease.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Alzheimer's Disease BACE1 cleaves APP to produce amyloid-beta, which accumulates in plaques, a hallmark of Alzheimer's disease. Increased BACE1 activity is associated with disease pathogenesis. OMIM: 604252; multiple studies
Mild Cognitive Impairment Elevated BACE1 activity in cerebrospinal fluid and brain tissue has been observed in individuals with mild cognitive impairment, a prodromal stage of Alzheimer's disease. PMID: 24632966
Down Syndrome Individuals with Down syndrome have an extra copy of APP, leading to increased amyloid-beta production. BACE1 activity is also elevated, contributing to early-onset Alzheimer's disease pathology. PMID: 23362280

Expression Profile

Tissue Expression
Tissue nTPM level
Brain High High
Pancreas Medium Medium
Testis Medium Medium
Liver Low Low
Kidney Low Low
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y High Neuroblastoma cell line; high BACE1 expression
HEK293 Medium Embryonic kidney cells; moderate expression
HeLa Low Cervical cancer cells; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
rs638405 SNP ~20% Associated with altered BACE1 expression and increased risk for Alzheimer's disease in some populations.
rs11247644 SNP ~10% May affect BACE1 splicing and activity.
c.1A>G Missense Rare Potential effect on protein function; not well characterized.
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations in BACE1 are rare and may lead to reduced amyloid-beta production, potentially protective against Alzheimer's disease, but may also cause other neurological issues.

Gain of Function (GOF)

Gain-of-function mutations or overexpression of BACE1 can increase amyloid-beta production, contributing to Alzheimer's disease pathology.

Dominant Negative (DN)

No dominant-negative mutations have been reported for BACE1.

Gene Ontology (GO)

• aspartic-type endopeptidase activity • peptidase activity
• protein homodimerization activity • amyloid-beta metabolic process
• proteolysis • membrane

Pathways

Alzheimer's disease pathway
Amyloid precursor protein processing
Notch signaling pathway (via cleavage of Notch receptors)

Protein Summary

Beta-secretase 1 (BACE1) is a type I transmembrane aspartic protease that cleaves the amyloid precursor protein (APP) at the beta-secretase site, generating the N-terminus of amyloid-beta peptides. It is primarily expressed in neurons and is the rate-limiting enzyme in amyloid-beta production. BACE1 is a major drug target for Alzheimer's disease; inhibitors are being developed to reduce amyloid-beta levels.

Related Products

Product name Cat.No. Species Gene ID
BACE1 Knockout HEK293 Cell Line EDJ-KQ17788 Human 23621 Details Get a Quote
BACE1 Knockout A-549 Cell Line EDJ-KQ19872 Human 23621 Details Get a Quote
BACE1 Knockout HCT 116 Cell Line EDJ-KQ19873 Human 23621 Details Get a Quote
BACE1 Knockout HeLa Cell Line EDJ-KQ19874 Human 23621 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: